Cargando…
Toxicokinetics of a humanized anti-cocaine monoclonal antibody in male and female rats and lack of cross-reactivity
A humanized monoclonal antibody h2E2 designed to bind cocaine with high affinity, specificity, and a long half-life (~7 d in rats) is being developed as a treatment for cocaine use disorder. We report here a pharmacokinetic (PK) study of h2E2 using male and female rats conducted under a Good Laborat...
Autores principales: | Webster, Rose P., Marckel, Jordan A., Norman, Andrew B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10653686/ https://www.ncbi.nlm.nih.gov/pubmed/37936497 http://dx.doi.org/10.1080/21645515.2023.2274222 |
Ejemplares similares
-
A humanized anti‐cocaine mAb antagonizes the cardiovascular effects of cocaine in rats
por: Koch, Sheryl E., et al.
Publicado: (2023) -
Effects of a recombinant humanized anti‐cocaine monoclonal antibody on the metabolism and distribution of cocaine in vitro and in mice
por: Turner, Mackenzie E., et al.
Publicado: (2022) -
Characterization of a recombinant humanized anti-cocaine monoclonal antibody and its Fab fragment
por: Kirley, Terence L, et al.
Publicado: (2015) -
Anti-tumor activity and toxicokinetics analysis of MGAH22, an anti-HER2 monoclonal antibody with enhanced Fcγ receptor binding properties
por: Nordstrom, Jeffrey L, et al.
Publicado: (2011) -
Improvement of Anti-CD36 Antibody Detection via Monoclonal Antibody Immobilization of Platelet Antigens Assay by Using Selected Monoclonal Antibodies
por: Xu, Xiuzhang, et al.
Publicado: (2023)